Literature DB >> 122905

Defective antibody response to bacteriophage phichi 174 in Down syndrome.

V Lopez, H D Ochs, H C Thuline, S D Davis, R J Wedgwood.   

Abstract

Antibody responses to bacteriophage phichi 174 were studied in 17 institutionalized patients with trisomy 21 and in six mentally retarded control patients with normal karyotype. Primary antibody response was significantly impaired in 11 of the 17 patients. Secondary immune response was normal in one, moderately impaired in seven, and very low in nine patients. Tertiary immunization further differentiated the two groups: those with moderately impaired secondary immune responses developed normal serum titers of predominantly IgG antibody; patients with low secondary immune responses had extemely impaired tertiary immune responses consisting mainly of serum IgM antibody.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 122905     DOI: 10.1016/s0022-3476(75)80469-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  11 in total

1.  Immunological and purine enzyme studies on hyperuricaemic and normouricaemic patients with Down's syndrome.

Authors:  R W Watts; Y S Perera; J Allsop; C Newton; T A Platts-Mills; A D Webster
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

2.  Serum antibody to poliovirus in patients in a mental deficiency hospital, with particular reference to Down's syndrome.

Authors:  E McKay; G Hems; A Massie; M A Moffat; K M Phillips
Journal:  J Hyg (Lond)       Date:  1978-08

3.  Cell-mediated cytotoxicity in Down syndrome: impairment of allogeneic mixed lymphocyte reaction, NK and NK-like activities.

Authors:  D Montagna; R Maccario; A G Ugazio; L Nespoli; E Pedroni; P Faggiano; G R Burgio
Journal:  Eur J Pediatr       Date:  1988-10       Impact factor: 3.183

4.  Lymphocyte subpopulations in Down's syndrome: high percentage of circulating HNK-1+, Leu 2a+ cells.

Authors:  R Maccario; A G Ugazio; L Nespoli; C Alberini; D Montagna; F Porta; F Bonetti; G R Burgio
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

5.  Monoclonal antibody defined T cell subsets and autologous mixed lymphocyte reaction in Down's syndrome.

Authors:  S Gupta; S M Fikrig; E Mariano; Q Quazi
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

6.  Antibody response to pneumococcal vaccine in patients with trisomy-21 (Down's syndrome).

Authors:  T Nurmi; M Leinonen; V M Häivä; A Tiilikainen; K Kouvalainen
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

Review 7.  Infections and immunodeficiency in Down syndrome.

Authors:  G Ram; J Chinen
Journal:  Clin Exp Immunol       Date:  2011-02-24       Impact factor: 4.330

8.  Immunological and virological investigations in Down's syndrome.

Authors:  G Fekete; G Kulcsár; P Dán; I Nász; D Schuler; M Dobos
Journal:  Eur J Pediatr       Date:  1982-02       Impact factor: 3.183

9.  Immunodeficiency in Down's syndrome: relationship between presence of human thyroglobulin antibodies and HBsAg carrier status.

Authors:  A G Ugazio; S D Jayakar; A F Marcioni; M Duse; V Monafo; F Pasquali; G R Burgio
Journal:  Eur J Pediatr       Date:  1977-10-12       Impact factor: 3.183

10.  The antibody response of institutionalized Down's syndrome patients to seven microbial antigens.

Authors:  R A Hawkes; C R Boughton; D R Schroeter
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.